We are seeking an enthusiastic and highly motivated Postdoctoral Research Associate to join the Birket Lab, an ambitious team pioneering research in human pluripotent stem cell (hPSC) biology to understand heart development and disease. This role offers the opportunity to lead transformative investigations into the molecular biology of Fabry disease, a rare and poorly understood lysosomal storage disorder (LSD) that affects the heart and kidneys.
Funded through an MRC project grant titled “Multi-tissue modelling of a lysosomal storage disorder using patient-derived iPSCs a pathway to Precision Medicine”, this research builds on the lab’s previous work on cardiac iPSC models of Fabry disease (Stem Cell Reports, 2019), cardiac organoids (The EMBO Journal, 2025) and their recent generation of five patient-derived iPSC lines (unpublished) in partnership with clinicians at Salford Royal Hospital.
Our vision is to uncover the mechanisms driving Fabry disease progression in the heart and kidney, with a focus on patient variability and the role of the immune system in fibrosis and organ failure. These investigations aim to identify novel biomarkers and therapeutic targets to support precision medicine for Fabry disease and other LSDs. To achieve these goals, cardiac and kidney organoids, with immune integration, will be used for multiparametric analyses including confocal imaging, single cell RNA-seq and proteomics. Particular emphasis will be placed on the role of the lysosomal protein LIMP-2 in disease progression.
The successful candidate will lead this project planning and performing experiments, maintaining and differentiating iPSCs, and characterising cells using flow cytometry and immunocytochemistry. They will analyse large-scale datasets, integrate findings with the literature, and contribute to manuscripts, presentations, and collaborations. The project will be supported by a dedicated technician. In addition to leading this work, they will support PhD students, help organise the lab, and play an active role in shaping future research directions.
Applicants should hold (or be close to completing) a PhD in molecular biology, stem cell biology, genetics or a related discipline, with strong technical skills in cell and molecular biology and experience in hPSC culture or models of heart/kidney development. Excellent communication skills, a collaborative mindset, and enthusiasm for contributing to a vibrant research environment are essential. Experience with single cell RNA-seq or proteomics data analysis would be advantageous.
This is a fulltime post available from March 1st, 2026, until 28th February 2028, with the possibility of an extension.
What you will get in return:
* Fantastic market leading Pension scheme
* Excellent employee health and wellbeing services including an Employee Assistance Programme
* Exceptional starting annual leave entitlement, plus bank holidays
* Additional paid closure over the Christmas period
* Local and national discounts at a range of major retailers
As an equal opportunities employer we welcome applicants from all sections of the community regardless of age, sex, gender (or gender identity), ethnicity, disability, sexual orientation and transgender status. All appointments are made on merit.
Our University is positive about flexible working you can find out more here
Hybrid working arrangements may be considered.
Please be aware that due to the number of applications we unfortunately may not able to provide individual feedback on your application.
Please note that we are unable to respond to enquiries, accept CVs or applications from Recruitment Agencies.
Any recruitment enquiries from recruitment agencies should be directed to People.Recruitment@manchester.ac.uk .
Any CV’s submitted by a recruitment agency will be considered a gift.
Enquiries about the vacancy, shortlisting and interviews:
Name: Dr Matthew Birket.
Email: matthew.birket@manchester.ac.uk
General enquiries:
Email: People.recruitment@manchester.ac.uk
Technical support:
0161 850 2004
This vacancy will close for applications at midnight on the closing date.
Please see the link below for the Further Particulars document which contains the person specification criteria.